Joshi; Yatindra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Joshi; Yatindra.The latest application filed is for "deuterated ruc-4".

Company Profile

0.5.30

Joshi; Yatindra - North Wales PA
Joshi; Yatindra - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Deuterated Ruc-4 App 20210361658 - Joshi; Yatindra	2021-11-25
Formulation App 20140287040 - Joshi; Yatindra ; et al.	2014-09-25
Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same Grant 8,475,839 - Cao , et al. July 2, 2	2013-07-02
Oral administration of a calcitonin Grant 8,410,052 - Joshi April 2, 2	2013-04-02
Formulation App 20130052239 - Joshi; Yatindra ; et al.	2013-02-28
Pharmaceutical compositions comprising hGH for oral delivery Grant 8,323,688 - Azria , et al. December 4, 2	2012-12-04
Solid Dosage Forms Of Valsartan And Amlodipine And Method Of Making The Same App 20120177733 - Joshi; Yatindra ; et al.	2012-07-12
Solid Dosage Forms Of Valsartan, Amlodipine And Hydrochlorothiazide And Method Of Making The Same App 20120164218 - Cao; Yu ; et al.	2012-06-28
Process for making compositions with poorly compressible therapeutic compounds App 20120077879 - Vasanthavada; Madhav ; et al.	2012-03-29
Modified Release 1- [ (3-hydroxy-adamant-1-ylamino)-acetyl] -pyrrolidine-2 (s) -carbonitrile Formulation App 20110086096 - KOWALSKI; JAMES ; et al.	2011-04-14
Formulation App 20110045062 - Joshi; Yatindra ; et al.	2011-02-24
Solid Dosage Forms Of Valsartan And Amlodipine And Method Of Making Same App 20100303906 - Joshi; Yatindra ; et al.	2010-12-02
Pharmaceutical Compositions Comprising Hgh For Oral Delivery App 20100247608 - Azria; Moise ; et al.	2010-09-30
Oral Administration Of A Calcitonin App 20100210526 - Joshi; Yatindra	2010-08-19
Process for making compositions with poorly compressible therapeutic compounds App 20100152299 - Vasanthavada; Madhav ; et al.	2010-06-17
Microemulsion Dosage Forms Of Valsartan And Methods Of Making The Same App 20100035949 - Joshi; Yatindra ; et al.	2010-02-11
Modified Release 1-[(3-Hydroxy-Adamant-1-Ylamino)-Acetyl]-Pyrrolidine-2(S)-Carbonitrile Formulation App 20100021539 - Kowalski; James ; et al.	2010-01-28
Solid Dosage Forms Of Valsartan, Amlodipine And Hydrochlorothiazide And Method Of Making The Same App 20100003321 - Cao; Yu ; et al.	2010-01-07
Solid Pharmaceutical Compositions Comprising Lumiracoxib App 20090149543 - Karnachi; Anees Abdulquadar ; et al.	2009-06-11
Pharmaceutical Composition Which Reduces Or Eliminates Drug Abuse Potential App 20090060848 - Joshi; Yatindra ; et al.	2009-03-05
Formulation App 20080227825 - Joshi; Yatindra ; et al.	2008-09-18
Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same App 20080171086 - Joshi; Yatindra ; et al.	2008-07-17
Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing Thereof App 20080050443 - Kowalski; James ; et al.	2008-02-28
Pharmaceutical composition which reduces or eliminates drug abuse potential App 20070148247 - Joshi; Yatindra ; et al.	2007-06-28
Pharmaceutical composition App 20070087051 - Holinej; Jurij ; et al.	2007-04-19
Pharmaceutical compositions App 20050123604 - Karnachi, Anees Abdulquadar ; et al.	2005-06-09
Pharmaceutical composition which reduces or eliminates drug abuse potential App 20040042964 - Joshi, Yatindra ; et al.	2004-03-04
Pharmaceutical composition App 20030171437 - Holinej, Jurij ; et al.	2003-09-11
Pharmaceutical composition which produces irritation App 20030147975 - Joshi, Yatindra ; et al.	2003-08-07
Pharmaceutical composition which produces irritation App 20030049272 - Joshi, Yatindra ; et al.	2003-03-13
Pharmaceutical composition which reduces or eliminates drug abuse potential App 20020187192 - Joshi, Yatindra ; et al.	2002-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.